The HEALthy Brain and Child Development Study (HBCD): NIH collaboration to understand the impacts of prenatal and early life experiences on brain development
- PMID: 39098249
- PMCID: PMC11342761
- DOI: 10.1016/j.dcn.2024.101423
The HEALthy Brain and Child Development Study (HBCD): NIH collaboration to understand the impacts of prenatal and early life experiences on brain development
Abstract
The human brain undergoes rapid development during the first years of life. Beginning in utero, a wide array of biological, social, and environmental factors can have lasting impacts on brain structure and function. To understand how prenatal and early life experiences alter neurodevelopmental trajectories and shape health outcomes, several NIH Institutes, Centers, and Offices collaborated to support and launch the HEALthy Brain and Child Development (HBCD) Study. The HBCD Study is a multi-site prospective longitudinal cohort study, that will examine human brain, cognitive, behavioral, social, and emotional development beginning prenatally and planned through early childhood. Influenced by the success of the ongoing Adolescent Brain Cognitive DevelopmentSM Study (ABCD Study®) and in partnership with the NIH Helping to End Addiction Long-term® Initiative, or NIH HEAL Initiative®, the HBCD Study aims to establish a diverse cohort of over 7000 pregnant participants to understand how early life experiences, including prenatal exposure to addictive substances and adverse social environments as well as their interactions with an individual's genes, can affect neurodevelopmental trajectories and outcomes. Knowledge gained from the HBCD Study will help identify targets for early interventions and inform policies that promote resilience and mitigate the neurodevelopmental effects of adverse childhood experiences and environments.
Keywords: Brain development; HBCD; Longitudinal; Neuroimaging; Prenatal substance use; Social determinants of health.
Copyright © 2024. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests. Julia L. Zehr reports a relationship with Jazz Pharmaceuticals Inc that includes: equity or stocks. Co-author’s spouse is employed by Jazz Pharmaceuticals, Inc - JLZ If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper
Figures

References
-
- Bakhireva L.N., Nebeker C., Ossorio P., Angal J., Thomason M.E., Croff J.M. Inclusion of American Indians and Alaskan Natives in large national studies: ethical considerations and implications for biospecimen collection in the HEALthy Brain and Child Development Study. Advers. Resil. Sci. 2020;1(4):285–294. doi: 10.1007/s42844-020-00020-8. - DOI - PMC - PubMed
-
- Beasley L.O., Ciciolla L., Jespersen J.E., Chiaf A.L., Schmidt M., Shreffler K.M., Breslin F.J., Bakhireva L.N., Sanjuan P.M., Stephen J.M., Coles C.D., Chambers C.D., Kable J.A., Leeman L., Singer L.T., Zellner J., Morris A.S., Croff J.M. Best practices for engaging pregnant and postpartum women at risk of substance use in longitudinal research studies: a qualitative examination of participant preferences. Advers. Resil. Sci. 2020;1(4):235–246. doi: 10.1007/s42844-020-00019-1. - DOI - PMC - PubMed
-
- Boggess T., Risher W.C. Clinical and basic research investigations into the long-term effects of prenatal opioid exposure on brain development. J. Neurosci. Res. 2022;100(1):396–409. - PubMed